• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HIN
Click for more information
0.00% $2.37

HEARTWARE INTERNATIONAL, INC

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
HIN
The Dollar Hedge 		12:21 0 394
12:21 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  394 
HIN
Insiders 		10/01/15 0 434
10/01/15 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  434 
HIN
Thoratec (THOR) Down 		13/11/14 0 301
13/11/14 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  301 
HIN
Small Healthcare 		10/10/14 6 1.3K
10/10/14 Last post  jooboy Comments Created with Sketch.  6  Views Created with Sketch.  1.3K 
HIN
germany cardiac assist devices market outlook 		01/06/14 0 334
01/06/14 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  334 
HIN
3 upgrades 		03/05/14 0 353
03/05/14 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  353 
HIN
tiny pump shrinks heart surgery 		28/04/14 1 462
28/04/14 Last post  pat done Comments Created with Sketch.  1  Views Created with Sketch.  462 
HIN
thoratec :class action 		26/01/14 0 343
26/01/14 Last post  pat done Comments Created with Sketch.  0  Views Created with Sketch.  343 

See All Discussions arrow Created with Sketch.

Top Stories

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.